Bernard Maillère

4.9k total citations
141 papers, 3.7k citations indexed

About

Bernard Maillère is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Bernard Maillère has authored 141 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Immunology, 48 papers in Molecular Biology and 26 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Bernard Maillère's work include Immunotherapy and Immune Responses (45 papers), T-cell and B-cell Immunology (29 papers) and vaccines and immunoinformatics approaches (26 papers). Bernard Maillère is often cited by papers focused on Immunotherapy and Immune Responses (45 papers), T-cell and B-cell Immunology (29 papers) and vaccines and immunoinformatics approaches (26 papers). Bernard Maillère collaborates with scholars based in France, United States and United Kingdom. Bernard Maillère's co-authors include Andre Ménèz, Catherine Texier, Florence Castelli, Mireille Hervé, Sandra Pouvelle‐Moratille, Cécile Buhot, Dominique Charron, Hassane M. Zarour, Marc Busson and Éric Tartour and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

Bernard Maillère

141 papers receiving 3.6k citations

Peers

Bernard Maillère
David H. Presky United States
Peter J. Kilshaw United Kingdom
Doris Scheidegger Switzerland
Robert W. Karr United States
W E Paul United States
P S Linsley United States
Bernard Maillère
Citations per year, relative to Bernard Maillère Bernard Maillère (= 1×) peers Toshitada Takemori

Countries citing papers authored by Bernard Maillère

Since Specialization
Citations

This map shows the geographic impact of Bernard Maillère's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Maillère with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Maillère more than expected).

Fields of papers citing papers by Bernard Maillère

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Maillère. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Maillère. The network helps show where Bernard Maillère may publish in the future.

Co-authorship network of co-authors of Bernard Maillère

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Maillère. A scholar is included among the top collaborators of Bernard Maillère based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Maillère. Bernard Maillère is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hansen, Bjarke Endel, Floris P. J. van Alphen, Paul Kaijen, et al.. (2024). FVIII peptides presented on HLA-DP and identification of an A3 domain peptide binding with high affinity to the commonly expressed HLA-DP4. Haematologica. 110(6). 1316–1327. 1 indexed citations
2.
Smadja, Claire, et al.. (2023). Infliximab aggregates produced in severe and mild elevated temperature stress conditions induce an extended specific CD4 T-cell response. European Journal of Pharmaceutical Sciences. 192. 106670–106670. 3 indexed citations
3.
Mathieu, Magali, et al.. (2023). Deciphering cross-species reactivity of LAMP-1 antibodies using deep mutational epitope mapping and AlphaFold. mAbs. 15(1). 2175311–2175311. 3 indexed citations
4.
Ihantola, Emmi‐Leena, Marja Rytkönen‐Nissinen, Bernard Maillère, et al.. (2020). Characterization of Proinsulin T Cell Epitopes Restricted by Type 1 Diabetes–Associated HLA Class II Molecules. The Journal of Immunology. 204(9). 2349–2359. 12 indexed citations
5.
Godet, Yann, Elizabeth Fabre, Magalie Dosset, et al.. (2012). Analysis of Spontaneous Tumor-Specific CD4 T-cell Immunity in Lung Cancer Using Promiscuous HLA-DR Telomerase-Derived Epitopes: Potential Synergistic Effect with Chemotherapy Response. Clinical Cancer Research. 18(10). 2943–2953. 76 indexed citations
6.
Ingram, Rebecca J., Gökhan Metan, Bernard Maillère, et al.. (2010). Natural Exposure to Cutaneous Anthrax Gives Long-Lasting T Cell Immunity Encompassing Infection-Specific Epitopes. The Journal of Immunology. 184(7). 3814–3821. 35 indexed citations
7.
Wambre, Erik, Mélodie Bonvalet, Bernard Maillère, et al.. (2010). Distinct characteristics of seasonal (Bet v 1) vs. perennial (Der p 1/Der p 2) allergen‐specific CD4+ T cell responses. Clinical & Experimental Allergy. 41(2). 192–203. 36 indexed citations
8.
Wang, Xiaofei, Jérôme Kerzerho, Olivier Adotévi, et al.. (2008). Comprehensive Analysis of HLA-DR- and HLA-DP4-Restricted CD4+ T Cell Response Specific for the Tumor-Shared Antigen Survivin in Healthy Donors and Cancer Patients. The Journal of Immunology. 181(1). 431–439. 35 indexed citations
9.
Jahn‐Schmid, Beatrice, Philémon Sirven, Victoria Leb, et al.. (2008). Characterization of HLA Class II/Peptide-TCR Interactions of the Immunodominant T Cell Epitope in Art v 1, the Major Mugwort Pollen Allergen. The Journal of Immunology. 181(5). 3636–3642. 19 indexed citations
10.
Kudela, Pavol, Bratislav Janjic, Julien Fourcade, et al.. (2007). Cross-Reactive CD4+ T Cells against One Immunodominant Tumor-Derived Epitope in Melanoma Patients. The Journal of Immunology. 179(11). 7932–7940. 6 indexed citations
11.
Gahéry, Hanne, Catherine Texier, Sandra Pouvelle‐Moratille, et al.. (2007). HLA-DR-Restricted Peptides Identified in The Nef Protein Can Induce HIV Type 1-Specific IL-2/IFN-γ-Secreting CD4 + And CD4 + /CD8 + T Cells in Humans after Lipopeptide Vaccination. AIDS Research and Human Retroviruses. 23(3). 427–437. 11 indexed citations
12.
Janjic, Bratislav, Xiaofei Wang, Julien Fourcade, et al.. (2006). Spontaneous CD4+ T Cell Responses against TRAG-3 in Patients with Melanoma and Breast Cancers. The Journal of Immunology. 177(4). 2717–2727. 15 indexed citations
13.
Pouvelle‐Moratille, Sandra, Xiaofei Wang, Dominique Charron, et al.. (2006). Scanning the HIV Genome for CD4+ T Cell Epitopes Restricted to HLA-DP4, the Most Prevalent HLA Class II Molecule. The Journal of Immunology. 176(9). 5401–5408. 18 indexed citations
14.
Mouquet, Hugo, P. Joly, Bernard Maillère, et al.. (2006). A Truncated Alternative Spliced Isoform of Human Desmoglein 1 Contains a Specific T Cell Epitope Binding to the Pemphigus Foliaceus-Associated HLA Class II DRβ1*0102 Molecule. The Journal of Immunology. 177(9). 6517–6526. 11 indexed citations
15.
Monneaux, Fanny, Johan Hoebeke, Christelle Sordet, et al.. (2005). Selective Modulation of CD4+ T Cells from Lupus Patients by a Promiscuous, Protective Peptide Analog. The Journal of Immunology. 175(9). 5839–5847. 49 indexed citations
16.
Mandić, Maja, Florence Castelli, Bratislav Janjic, et al.. (2005). One NY-ESO-1-Derived Epitope That Promiscuously Binds to Multiple HLA-DR and HLA-DP4 Molecules and Stimulates Autologous CD4+ T Cells from Patients with NY-ESO-1-Expressing Melanoma. The Journal of Immunology. 174(3). 1751–1759. 57 indexed citations
17.
Kinnunen, Tuure, Cécile Buhot, Ale Närvänen, et al.. (2003). The immunodominant epitope of lipocalin allergen Bos d 2 is suboptimal for human T cells. European Journal of Immunology. 33(6). 1717–1726. 22 indexed citations
19.
Zhang, Yi, Pascal Chaux, Vincent Stroobant, et al.. (2003). A MAGE-3 Peptide Presented by HLA-DR1 to CD4+ T Cells That Were Isolated from a Melanoma Patient Vaccinated with a MAGE-3 Protein. The Journal of Immunology. 171(1). 219–225. 35 indexed citations
20.
Texier, Catherine, Marc Busson, Mireille Hervé, et al.. (2000). HLA-DR Restricted Peptide Candidates for Bee Venom Immunotherapy. The Journal of Immunology. 164(6). 3177–3184. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026